Instylla, Inc., a developer of resorbable embolics for peripheral vascular embolization, announced that the FDA has approved an ...

AdvaMed, the Advanced Medical Technical Association, announced it recommended refinements to the Centers for Medicare & Med ...

Siemens Healthineers announced the strategic focus of its ultrasound business is shifting to procedural imaging and image-guide ...

The United Kingdom’s Medicines and Healthcare Agency (MHRA) announced that the government confirmed it will continue to a ...

IceCure Medical Ltd., developer of minimally invasive cryoablation technology, announced the enrollment of the first two ...

Front Line Medical Technologies Inc. COBRA-OS REBOA (large vessel balloon occlusion device; 4-F; 25-mm diameter-balloon; guidewire-free) Distal Intended for temporary occlusion of large vessels ...

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.